Macrogenics (MGNX) Receivables - Other (2014 - 2015)
Macrogenics' (MGNX) quarterly Receivables - Other came in at $900000.0 in Q3 2015, up 118.18% year-on-year from $412500.0 in Q3 2014, and up 12.5% on a QoQ basis from $800000.0 in Q2 2015.
Macrogenics (MGNX) Receivables - Other (2014 - 2015) Analysis & Trends
Macrogenics (MGNX) has 2 years of Receivables - Other data on file, last reported at $900000.0 in Q3 2015.
- On a quarterly basis, Receivables - Other rose 118.18% year-over-year to $900000.0 in Q3 2015; TTM through Sep 2015 was $900000.0, a 118.18% increase from a year earlier, with the FY2014 full-year figure at $500000.0, changed N/A from the prior year.
- Receivables - Other for Q3 2015 stood at $900000.0, up from $800000.0 in the prior quarter.
- Over the last five years, Receivables - Other for MGNX reached as high as $900000.0 in Q3 2015 and fell as low as $0.6 in Q1 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Macrogenics | 254.43 Mn | 187.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | 900,000.00 |
| Sep 30, 2015 | 900,000.00 |
| Jun 30, 2015 | 800,000.00 |
| Jun 30, 2015 | 800,000.00 |
| Mar 31, 2015 | 0.60 |
| Mar 31, 2015 | 0.60 |
| Dec 31, 2014 | 500,000.00 |
| Dec 31, 2014 | 500,000.00 |
| Sep 30, 2014 | 412,500.00 |
| Sep 30, 2014 | 412,500.00 |